110936 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Metapneumovirus, e.g. avian pneumovirus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#2RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE
#3Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use
#4VACCINE COMPOSITION AGAINST TWO RESPIRATORY VIRUSES
#5PAN-PNEUMOVIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
#6HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES
#7ANTIBODIES THAT BIND METAPNEUMOVIRUS, ANTIGENIC METAPNEUMOVIRUS PROTEINS, AND USES THEREOF
#8PREFUSION-STABILIZED CHIMERIC HMPV-RSV F PROTEINS
#9Respiratory syncytial virus mRNA vaccine
#10HUMAN METAPNEUMO VIRUS VACCINE
#11Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use
#12Recombinant metapneumovirus f proteins and their use
#13RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE
#14ENGINEERED NEWCASTLE DISEASE VIRUS VECTOR AND USES THEREOF
#15Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use
#16Recombinant metapneumovirus F proteins and their use
#17Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#18Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use
#19Virus causing respiratory tract illness in susceptible mammals
#20Recombinant metapneumovirus F proteins and their use
#21Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof
#22Virus causing respiratory tract illness in susceptible mammals
#23Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#24Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#25Virus causing respiratory tract illness in susceptible mammals
#26Recombinant metapneumovirus F proteins and their use
#27Virus causing respiratory tract illness in susceptible mammals
#28strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#29Virus causing respiratory tract illness in susceptible mammals
#30Virus causing respiratory tract illness in susceptible mammals
#31Alphavirus vectors for respiratory pathogen vaccines
#32Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#33Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#34Vaccine
#35RECOMBINANT PARAINFLUENZA VIRUS VACCINE COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM RESPIRATORY SYNCYTIAL VIRUS
#36Alphavirus Vectors for Respiratory Pathogen Vaccines
#37Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#38NUCLEIC ACID SEQUENCES FOR THE AMPLIFICATION AND DETECTION OF RESPIRATORY VIRUSES
#39METAPNEUMOVIRUS STRAINS AND THEIR USE IN VACCINE FORMULATIONS AND AS VECTORS FOR EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS FOR PROPAGATING VIRUS
#40Metapneumovirus strains and their use in vaccine formulations and sequences
#41Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#42Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#43Alphavirus Vectors for Respiratory Pathogen Vaccines
#44Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#45Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
#46Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
#47Molecular methods and compositions for detecting and quantifying respiratory viruses
#48Attenuation of metapneumovirus
#49Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#50Virus causing respiratory tract illness in susceptible mammals
#51Virus causing respiratory tract illness in susceptible mammals
#52Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making
#53Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus